|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0013089,
umls-concept:C0016360,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0206624,
umls-concept:C0280673,
umls-concept:C0444889,
umls-concept:C0684224,
umls-concept:C1516476,
umls-concept:C1518932,
umls-concept:C1707455
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2000-8-1
|
|
pubmed:abstractText |
Previous studies demonstrated that chemotherapy with either cisplatin, vincristine, and fluorouracil (regimen A) or cisplatin and continuous infusion doxorubicin (regimen B) improved survival in children with hepatoblastoma. The current trial is a randomized comparison of these two regimens.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:DouglassE CEC,
pubmed-author:FeusnerJ HJH,
pubmed-author:FinegoldM JMJ,
pubmed-author:HaasJ EJE,
pubmed-author:KingD RDR,
pubmed-author:KrailoM DMD,
pubmed-author:Liu-MaresWW,
pubmed-author:OrtegaJ AJA,
pubmed-author:QuinnJ JJJ,
pubmed-author:ReynoldsMM,
pubmed-author:SenselM GMG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2665-75
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10894865-Antibiotics, Antineoplastic,
pubmed-meshheading:10894865-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10894865-Child,
pubmed-meshheading:10894865-Child, Preschool,
pubmed-meshheading:10894865-Cisplatin,
pubmed-meshheading:10894865-Combined Modality Therapy,
pubmed-meshheading:10894865-Doxorubicin,
pubmed-meshheading:10894865-Female,
pubmed-meshheading:10894865-Fluorouracil,
pubmed-meshheading:10894865-Hepatoblastoma,
pubmed-meshheading:10894865-Humans,
pubmed-meshheading:10894865-Infant,
pubmed-meshheading:10894865-Liver Neoplasms,
pubmed-meshheading:10894865-Male,
pubmed-meshheading:10894865-Neoplasm Staging,
pubmed-meshheading:10894865-Proportional Hazards Models,
pubmed-meshheading:10894865-Survival Analysis,
pubmed-meshheading:10894865-Treatment Outcome,
pubmed-meshheading:10894865-Vincristine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
|
|
pubmed:affiliation |
Division of Hematology/Oncology, Children's Hospital of Los Angeles, CA, USA. JORTEGA@CHILA@CHLA.USC.EDU
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
